Dorothy E Schumm

Title: Dorothy E Schumm: Innovator in Cancer Treatment

Introduction

Dorothy E Schumm is a prominent inventor based in Patriot, OH (US). She has made significant contributions to the field of cancer treatment, holding a total of 6 patents. Her innovative work focuses on developing low-cost and less toxic immunotherapies that enhance the host's immune system to combat cancer.

Latest Patents

Among her latest patents is a method for treating cancer with monoclonal antibodies to oncofetal protein (OFP). This invention provides a novel approach to anti-cancer immunotherapy, which not only enhances the immune system's ability to destroy or contain cancers but also offers a diagnostic test for cancer. Tumors treated with a single dose of these monoclonal antibodies show a marked reduction in size, while leukemic cell populations significantly decrease in number. The monoclonal antibodies do not bind to tumor cells, thus overcoming the disadvantages associated with traditional tumor cell targeting. This innovative treatment offers a simple and inexpensive option for primary or adjuvant therapy against various cancers in humans and animals.

Career Highlights

Dorothy E Schumm is affiliated with The Ohio State University, where she continues her research and development in cancer therapies. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Some of her notable coworkers include Thomas E Webb and Paul C Stromberg, who have collaborated with her on various research projects.

Conclusion

Dorothy E Schumm's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work not only advances medical science but also offers hope for improved cancer therapies.